Table 1. Relative survival for Australian children diagnosed with cancer by diagnostic group, 1997–2006a.
|
Relative survival (95% confidence intervals)
|
||||
|---|---|---|---|---|
| Diagnostic group | N b | 1 year | 5 year | 20 year |
| All cancers | 11 903 | 90.6 (89.8–91.3) | 79.6 (78.5–80.6) | 74.8 (73.7–76.0) |
| I. Leukaemias | 3833 | 92.8 (91.6–93.8) | 80.6 (78.8–82.2) | 75.9 (73.9–77.8) |
| IA Lymphoid leukaemias | 3121 | 96.3 (95.3–97.1) | 85.0 (83.1–86.7) | 79.7 (77.5–81.7) |
| IB Acute myeloid leukaemias | 537 | 79.2 (74.5–83.2) | 63.4 (57.9–68.4) | 62.3 (56.7–67.5) |
| II. Lymphomas | 1220 | 93.5 (91.3–95.2) | 89.8 (87.1–92.0) | 88.0 (84.8–90.6) |
| IIA. Hodgkin lymphomas | 500 | 98.8 (96.4–99.6) | 97.7 (94.7–99.0) | 95.4 (91.4–97.8) |
| IIB. Non-Hodgkin lymphomas (excl. Burkitt lymphoma) | 486 | 90.2 (85.4–93.4) | 81.7 (76.0–86.1) | 79.5 (73.2–84.6) |
| IIC. Burkitt lymphoma | 206 | 90.3 (83.5–94.4) | 90.4 (83.6–94.4) | 91.2 (84.3–95.3) |
| III. Tumours of the CNSc | 2562 | 82.6 (80.5–84.5) | 71.0 (68.5–73.3) | 64.4 (61.6–67.0) |
| IIIA. Ependymomas and choroid plexus tumours | 242 | 88.8 (81.8–93.2) | 69.3 (60.6–76.4) | 62.2 (53.2–69.9) |
| IIIB. Astrocytomas | 1266 | 87.3 (84.4–89.6) | 78.8 (75.5–81.8) | 71.7 (67.6–75.4) |
| IIIC. Intracranial & intraspinal embryonal tumours | 437 | 70.0 (64.1–75.1) | 48.7 (42.6–54.5) | 41.7 (35.5–47.7) |
| IIID. Other gliomas | 267 | 65.2 (57.4–71.9) | 55.1 (47.1–62.3) | 48.9 (40.6–56.7) |
| IV. Neuroblastoma | 650 | 87.8 (84.0–90.8) | 67.8 (62.7–72.4) | 64.2 (58.7–69.1) |
| V. Retinoblastoma | 348 | 99.6 (95.6–100.0) | 98.4 (94.5–99.7) | 97.8 (92.8–99.7) |
| VI. Renal tumours | 683 | 95.5 (92.7–97.3) | 88.6 (84.6–91.6) | 86.9 (82.5–90.4) |
| VII. Hepatic tumours | 153 | 85.5 (76.7–91.2) | 76.0 (66.0–83.4) | 74.4 (63.8–82.4) |
| VIII. Malignant bone tumours | 494 | 93.6 (89.6–96.0) | 68.9 (62.8–74.2) | 64.1 (57.7–69.8) |
| IX. Soft tissue sarcomas | 693 | 90.6 (87.0–93.3) | 72.1 (67.0–76.6) | 65.2 (59.8–70.1) |
| IXA. Rhabdomyosarcomas | 343 | 92.8 (87.6–95.9) | 71.7 (63.9–78.2) | 65.3 (57.2–72.2) |
| X. Germ cell tumorsc | 467 | 92.2 (88.0–95.0) | 89.4 (84.7–92.7) | 85.0 (79.2–89.3) |
| XI. Other malignant epithelial neoplasms & melanomas | 776 | 96.8 (94.2–98.2) | 93.3 (90.1–95.5) | 86.5 (81.4–90.3) |
| XID. Malignant melanomas | 493 | 99.0 (96.1–99.8) | 97.5 (94.3–99.0) | 91.1 (84.7–95.0) |
| XII. Other & unspecified | 24 | 77.4 (45.1–92.2) | 72.2 (41.7–88.7) | 58.3 (29.4–79.0) |
a
Includes all children who were diagnosed between January 1st 1983 and December 31st 2006, and were ‘at risk’ at some point between 1997 and 2006 (inclusive).
b
N represents the total number at risk between 1997 and 2006 (inclusive).
c
Includes cancers of benign or uncertain behaviour.